Molecular Insights Into MR1 ‐Mediated T Cell Immunity: Lessons Learned and Unanswered Questions
Immunological Reviews · 2025
DOI: 10.1111/imr.70033 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Immunological Reviews, 2025. Verfasst von Wael Awad und 4 weiteren Autor:innen. Beteiligte Einrichtung: Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Vic…. Hauptthemen laut MEDLINE: Histocompatibility Antigens Class I, Minor Histocompatibility Antigens, Mucosal-Associated Invariant T Cells, T-Lymphocytes. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Australian Academy of science (ARC), NHMRC Investigator, Australian ARC Discovery Early Career Researcher Award.
Abstract (Originalsprache)
The major histocompatibility complex class‐I related protein, MR1, is an evolutionarily conserved antigen presenting molecule that binds and displays organic metabolites to T cells, including mucosal associated invariant T (MAIT) cells and diverse MR1‐restricted T cells (MR1T). Structural studies have elucidated how MR1 can accommodate a range of chemical scaffolds that arise from foreign, synthetic, and self‐metabolites, although the full spectrum of metabolites that MR1 presents remains unclear. Presently, MAIT and MR1T cell recognition of MR1‐antigen complexes represents a new immune recognition paradigm and is emerging as a critical player in protective immunity, aberrant immunity, tumor immunity, and tissue repair. Moreover, the limited allelic variation of MR1 makes it an attractive therapeutic target. This review will address the unique features and capability of the MR1 molecule to display several classes of small molecules for T cell surveillance. We will also address the molecular basis underlying MAIT and MR1T TCR recognition of MR1‐binding ligands.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.
- Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia.
- Institute of Infection and Immunity, Cardiff University School of Medicine, Cardiff, UK.
ORCID-Profile: Wael Awad
Förderung
- Australian Academy of science (ARC)
- NHMRC Investigator
- Australian ARC Discovery Early Career Researcher Award
- National Health and Medical Research Council of Australia
- Monash FMNHS Future Leader Fellowship
- NIAID NIH HHS
- ARC Discovery Grant
- US National Institutes of Health (NIH)
Zitieren
APA
Awad, W., Abdelaal, M. R., Letoga, V., McCluskey, J., & Rossjohn, J. (2025). Molecular Insights Into MR1 ‐Mediated T Cell Immunity: Lessons Learned and Unanswered Questions. Immunological Reviews. https://doi.org/10.1111/imr.70033
Vancouver
Awad W, Abdelaal MR, Letoga V, McCluskey J, Rossjohn J. Molecular Insights Into MR1 ‐Mediated T Cell Immunity: Lessons Learned and Unanswered Questions. Immunological Reviews. 2025. doi:10.1111/imr.70033
BibTeX
@article{Awad2025,
author = {Awad, Wael and Abdelaal, Mohamed R and Letoga, Victoria and McCluskey, James and Rossjohn, Jamie},
title = {Molecular Insights Into MR1 ‐Mediated T Cell Immunity: Lessons Learned and Unanswered Questions},
journal = {Immunological Reviews},
year = {2025},
doi = {10.1111/imr.70033}
}
EUVIMED